Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the ninja-forms domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/wp-includes/functions.php on line 6114
Generic Peptide – PSYCLO PEPTIDE,INC.
PSYCLO PEPTIDE,INC.
Generic Peptide

Generic Peptide

We provide research use generic peptides as following, for bulky order upto hundred grams or above please inquire us.  Psyclo Peptide,Inc. provides sourcing service to good quality pharma-grade peptide APIs for our customers worldwide.

adrenomedullin-872350

Buy from our on-line shop just one-click the button below. For bulky order, please inquire order@psyclopeptide.com

Besides, we also provide the peptides as follows,

No English Name Cas No. Scale Specification
1 Abarelix 183552-38-7 R&D In-house
2 Atosiban 90779-69-4 Commercial In-house
3 Aviptadil 40077-57-4 R&D In-house
4 Angiotensin II 4474-91-3 R&D In-house
5 Antide 112568-12-4 R&D In-house
6 Vasporessin 11000-17-2 Commercial USP
7 Buserelin Acetate 68630-75-1 Commercial EP
8 Caspofungin Acetate 179463-17-3 Commercial In-house
9 Calcitonin (Salmon) 47931-85-1 Pilot EP
10 Carbetocin 37025-55-1 Commercial In-house
11 Carperitide 89213-87-6 R&D In-house
12 Cetrorelix Acetate 120287-85-6 Pilot In-house
13 Elcatonin 57014-02-5 R&D In-house
14 Enfuvirtide 159519-65-0 R&D In-house
15 Exenatide Acetate 141758-74-9 Pilot In-house
16 Fertirelin Acetate 66002-66-2 R&D In-house
17 GLP-1(7-36) amide 107444-51-9 R&D In-house
18 GLP-1 (7-37) 106612-94-6 R&D In-house
19 Gonadorelin Acetate 71447-49-9 Pilot EP
20 Goserelin Acetate 145781-92-6 Commercial EP/USP
21 Histrelin Acetate 220810-26-4 Commercial In-house
22 Icatibant 30308-48-4 R&D In-house
23 Lanreotide Acetate 108736-35-2 R&D In-house
24 Liraglutide 204656-20-2 Pilot In-house
25 Lysipressin 50-57-7 Commercial In-house
26 Nafarelin 86220-42-0 R&D In-house
27 Oxytocin 50-56-6 Commercial EP/USP
28 Pramlintide Acetate 196078-30-5 Pilot In-house
29 Protirelin 24305-27-9 Commercial EP
30 Sincalide Acetate 25126-32-3 R&D USP
31 Somatostatin 38916-34-6 Commercial EP/Ch.P
32 Terlipressin 14636-12-5 Commercial EP/In-house
33 Teriparatide Acetate 52232-67-4 R&D In-house
34 Thymopentin Acetate 177966-81-3 Commercial Ch.P
35 Thymosin β4 Acetate 77591-33-4 R&D In-house
36 Thymalfasin 62304-98-7 Commercial Ch.P
37 Triptorelin Acetate 140194-24-7 Commercial In-house
38 Micafungin 235114-32-6 Pilot In-house
39 Linaclotide Acetate 851199-60-5 Lab In-house
40 Degarelix 214766-78-6 Pilot In-house
41 Telavacin 372151-71-8 R&D In-house
42 Oritavancin 171099-57-3 R&D In-house
43 Dalbavancin 171500-79-1 R&D In-house
400500-3176417_1920

 Cosmetic Peptide

 

Anti-aging Peptide Cosmeceuticals

Cosmeceutical research is a rapid growing area in personal care sectors, which extends from facial products to skin and body products. A forecasted report suggested that by 2018, the global market for cosmeceuticals will reach 42 billion dollars and lead to a great demand in near future. Aging is the critical factor that causes skin collagen to lose its physical appearance in many ways such as oil production decrease, dry skin, texture loss, age spots, and loose skin. Aging causes skin thinning, and the end result is wrinkle formation. This is not limited to the aged population; younger individuals exposed to various harsh environmental conditions such as infrared and ultraviolet rays, chemical pollution, and other physical stresses can also be affected. Skin aging is a complicated biochemical progression resulting from many individual intrinsic and extrinsic factors such as age, hormones and exposure to UV light. Chronologically aged skin induced by UV radiation occurs through an increase in MMPs production, including, MMP-1, MMP-2, MMP-3 and MMP-9, which causes an imbalance of collagen synthesis by the induction of collagen or by ECM degradation. The progression occurs in the epidermal and dermal layers and is mainly related to extracellular matrix (ECM) degradation. The enzymes involved in ECM degradation are matrix metalloproteinases (MMPs) such as gelatinases (MMP-2) and collagenase. Skin loses its tensile strength due to the effect of ECM degradation by MMPs. In this process, the wrinkling of skin occurs and roughness and dryness also markedly arise along with certain pigment abnormalities such as hypo- or hyper-pigmentation. Hyperpigmentation causes human skin aging and occurs as a result of both internal and external factors including those related to hormones, UV exposure, drugs, and the presence of various chemicals. Melanin biosynthesis is a pathway that appears in melanocytes.Cosmetic scientists have conducted various in vivo and in vitro studies on skin lightening agents. The key enzyme that regulates melanin synthesis is tyrosinase. Tyrosinase is a rate-limiting enzyme that converts tyrosine to melanin. Tyrosine inhibitors thus play an importance role as skin-lightening agents.

Collagen synthesis in skin fibroblasts plays a major role in skin rejuvenation. The reduction of types I and III procollagen synthesis is a critical feature of aged skin leading to skin thinning and the increased fragility of skin. Hence, the inhibition of collagen synthesis or a loss in the function of collagen results in chronologically aged skin.

Peptides have important applications in modulating of skin cell proliferation, cell migration, inflammation, angiogenesis, melanogenesis, and protein synthesis and regulation. With variations in amino acid sequence, number of amino acids and derivatives, the future of peptide based cosmeceuticals is bright.

 

Cat. No. Product CAS Sequence
1801003 SYN-AKE 823202-99-9 beta-Ala-Pro-Dab-NHBzl
1801004 Palmitoyl tripeptide-38 1447824-23-8 Lys-Met(O2)-Lys
1801008 Copper Tripeptide-34 (Ala-His-Lys)2.Cu
1801012 Palmitoyl Tripeptide-1 147732-56-7 Palmitoyl-Gly-His-Lys
1801013 Biotinoyl Tripeptide-1 299157-54-3 Biotin-Gly-His-Lys
1801015 Copper Tripeptide-1 89030-95-5 (Gly-His-Lys)2.Cu
1801016 Acetyl Tetrapeptide-3 827306-88-7 Ac-Lys-Gly-His-Lys
1801018 Acetyl Tetrapeptide-2 757942-88-4 Ac-Lys-Asp-Val-Tyr
1801019 Acety Hexapeptide-3 616204-22-9 Ac-Glu-Glu-Met-Gln-Arg-Arg-NH2
1801020 Palmitoyl Pentapeptide-3 214047-00-4 Palmitoyl-Lys-Thr-Thr-Lys-Ser
1801021 Acetyl Octapeptide-3 868844-74-0 Ac-Glu-Glu-Met-Gln-Arg-Arg-Ala-Asp-NH2
1801027 Palmitoyl Tripeptide-5 623172-55-4 Palmitoyl-Lys-Val-Lys-OH
1801028 Acetyl Tetrapeptide-5 820959-17-9 Ac-beta-Ala-His-Ser-His
1801029 Dipeptide-2 24587-37-9 Val-Trp
1801030 Pentapeptide-18 64963-01-5 Tyr-D-Ala-Gly-Phe-Leu
1801032 VGVAPG 124861-55-8 Val-Gly-Val-Ala-Pro-Gly
1801033 Acetyl tetrapeptide-15 928007-64-1 Tyr-Pro-Phe-Phe
1801034 Palmitoyl tetrapeptide-7 221227-05-0 Palmitoyl-Gly-Gln-Pro-Arg
1801035 Pentapeptide-3 725232-44-0 Gly-Pro-Arg-Pro-Ala-NH2
1801036 Myristoyl Pentapeptide-17 959610-30-1 Myristoyl-Lys-Leu-Ala-Lys-Lys-NH2
1801038 Palmitoyl hexapeptide-12 171263-26-6 Palmitoyl-Val-Gly-Val-Ala-Pro-Gly
1801042 Thymogen 122933-59-9 Glu-Trp

*All materials are not for directly human use.